Publications

Yang, W., Guo, X., Tu, Z. et al. PINK1 kinase dysfunction triggers neurodegeneration in the primate brain without impacting mitochondrial homeostasis. Protein Cell (2021). https://doi.org/10.1007/s13238-021-00888-x

Song, D., Liu, X., Dong, C. et al. Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity. Sci Rep 11, 22966 (2021). https://doi.org/10.1038/s41598-021-02449-y

Zhang, D., Huang, J., Wang, F. et al. BMI1 regulates multiple myeloma-associated macrophage’s pro-myeloma functions. Cell Death Dis 12, 495 (2021). https://doi.org/10.1038/s41419-021-03748-y

Qiao, X., Ma, J., Knight, T. et al. The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML. Blood Cancer J. 11, 111 (2021). https://doi.org/10.1038/s41408-021-00502-7

Liu Y, Zhou Y, Huang KH, Fang X, Li Y, Wang F, An L, Chen Q, Zhang Y, Shi A, Yu S, Zhang J. Targeting epidermal growth factor-overexpressing triple-negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor. Cell Prolif. 2020 Aug;53(8):e12858. doi: 10.1111/cpr.12858. Epub 2020 Jun 27. PMID: 32592435; PMCID: PMC7445407.

Xu Y, Wang P, Li M, Wu Z, Li X, Shen J, Xu R. Natural small molecule triptonide inhibits lethal acute myeloid leukemia with FLT3-ITD mutation by targeting Hedgehog/FLT3 signaling. Biomed Pharmacother. 2021 Jan;133:111054. doi: 10.1016/j.biopha.2020.111054. Epub 2020 Nov 27. PMID: 33254022.

Zhai X, You F, Xiang S, Jiang L, Chen D, Li Y, Fan S, Han Z, Zhang T, An G, Zhang B, Chen Y, Meng H, Yang L. MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity. Am J Cancer Res. 2021 Jan 1;11(1):79-91. PMID: 33520361; PMCID: PMC7840711.

Tu C, Du Z, Zhang H, Feng Y, Qi Y, Zheng Y, Liu J, Wang J. Endocytic pathway inhibition attenuates extracellular vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells. Theranostics. 2021 Jan 1;11(5):2364-2380. doi: 10.7150/thno.47996. PMID: 33500730; PMCID: PMC7797667.

Hu Z, Zheng X, Jiao D, Zhou Y, Sun R, Wang B, Tian Z, Wei H. LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer. Mol Ther Oncolytics. 2020 Apr 21;17:361-370. doi: 10.1016/j.omto.2020.04.008. PMID: 32405534; PMCID: PMC7210386.

Chen T, Ding X, Liao Q, Gao N, Chen Y, Zhao C, Zhang X, Xu J. IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy. J Immunother Cancer. 2021 Jan;9(1):e001647. doi: 10.1136/jitc-2020-001647. PMID: 33504576; PMCID: PMC7843316.